VBData reported：SynRx Therapeutics: Development of next-generation anti-cancer drugs targeting DNA damage repair based on "synthetic lethal" strategy
Cancer is one of the most serious diseases that humans are faced up with today, and the development of cancer is often closely linked to the process of cellular DNA damage...
Release time： 2022-01-08
